William Fricker

Mr. Fricker was appointed their chief financial officer in 2022. Mr. Fricker has over 25 years of financial leadership experience in both public and private companies. Mr. Fricker is the former CFO of Neurorx Inc. (2020-2021) and was Vice President, Finance & Principal Accounting Officer of Immunomedics Inc. (2018-2020). Previously, Mr. Fricker held senior accounting and finance positions at J.M Huber Corporation, Johnson & Johnson, and Bristol-Myers Squib. Mr. Fricker is a certified public accountant and was formerly a Senior Auditor at Coopers & Lybrand.

He received a B.S. degree in accounting from Penn State in 1985, and an MBA in 1996, from Villanova University.